why choose us

First received: November 30, 2022

Clinical Trial: Study of AV-1959, an Amyloid Beta Vaccine

Study Status: Completed

Recruit Status: RECRUITING

Condition: Alzheimer Disease

Study Type: INTERVENTIONAL


Official Title: A Phase I, Randomized, Double-Blind Study to Evaluate Safety and Tolerability of Amyloid-? Vaccine, AV-1959D, in Patients With Early Alzheimer's Disease.

Brief Summary: Phase 1 clinical trial of AV-1959 amyloid-? vaccine for Alzheimer's disease (AD).

Read more